{
    "SPADE_UN_15309": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15309",
            "Peptide Name": 17,
            "Source": "Synthetic",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "YXGFM",
            "Sequence Length": 5,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)",
            "Hemolytic Activity": "Not available",
            "Cytotoxicity": "Not available",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C25H30N4O5S",
            "Mass": 68012,
            "PI": 6.09,
            "Net Charge": 0,
            "Hydrophobicity": 0.6,
            "Half Life": "Mammalian:2.8 hourYeast:10 minE.coli:2 min",
            "Comments": "lead to apoptosis",
            "Literature": [
                {
                    "Title": "Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids design, synthesis, and in vitro antitumor activity",
                    "Pubmed ID": "16722632",
                    "Reference": "J Med Chem. 2006 Jun 1;49(11)3136-42.",
                    "Author": "Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16722632"
                }
            ],
            "Frequent Amino Acids": "FGM",
            "Absent Amino Acids": "ACDEHIKLNOPQRSTUVW",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 1,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00639",
                    "Similarity": 1.0,
                    "Sequence": "YEDSCSTDEECRRNCLCDVAYCDKSRDKCDYGFMNRVDVRFPKHPYISKNKDGSGR"
                },
                {
                    "SPADE_ID": "SPADE_N_05272",
                    "Similarity": 1.0,
                    "Sequence": "MNEEKLKMILLLLEDIPRDEWNRLVNEVNNQYSYQADKVGLASDNCQQIANNYKHYGF"
                },
                {
                    "SPADE_ID": "SPADE_N_05628",
                    "Similarity": 1.0,
                    "Sequence": "VVYALKRNGRTLYGF"
                }
            ]
        }
    }
}